CSPC Pharmaceutical Group Limited
CSPCY · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $88,396,514 | $53,797,993 | $72,358,594 | $85,360,762 |
| - Cash | $7,570,931 | $6,777,199 | $8,370,714 | $11,979,646 |
| + Debt | $495,000 | $507,330 | $388,870 | $706,901 |
| Enterprise Value | $81,320,583 | $47,528,124 | $64,376,750 | $74,088,017 |
| Revenue | $1,829,618 | $14,591,337 | $16,276,552 | $7,585,033 |
| % Growth | -87.5% | -10.4% | 114.6% | – |
| Gross Profit | $1,200,620 | $9,950,243 | $11,649,015 | $18,678,314 |
| % Margin | 65.6% | 68.2% | 71.6% | 246.3% |
| EBITDA | $3,480,614 | $2,497,898 | $4,524,819 | $1,788,632 |
| % Margin | 190.2% | 17.1% | 27.8% | 23.6% |
| Net Income | $351,198 | $1,586,394 | $3,018,940 | $1,378,684 |
| % Margin | 19.2% | 10.9% | 18.5% | 18.2% |
| EPS Diluted | 0.12 | 0.48 | 1.08 | 1.44 |
| % Growth | -75% | -55.6% | -25% | – |
| Operating Cash Flow | $455,837 | $3,308,449 | $1,424,748 | $3,144,602 |
| Capital Expenditures | -$165,850 | $648,891 | -$648,891 | -$890,222 |
| Free Cash Flow | $289,986 | -$775,858 | $775,858 | $1,957,440 |